MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), today began the international launch of the Driver Sprint RX Coronary Stent System, which received the CE (Conformité Européene) Mark in February 2009 and is planned to be commercially available in more than 100 countries worldwide.